Financhill
Back

Atreca 10K Form

Sell
18

BCEL
Atreca

Last Price:
0.07
Seasonality Move:
-12.87%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive BCEL News And Ratings

See the #1 stock for the next 7 days that we like better than BCEL

BCEL Financial Statistics

Sales & Book Value

Annual Sales: --
Cash Flow: $-17.28M
Price / Cash Flow: 0
Annual Sales: $0.27
Price / Book: 0.28

Profitability

EPS (TTM): -2.50000
Net Income (TTM): $-97.76M
Gross Margin: --
Return on Equity: 0%
Return on Assets: 0%

Atreca Earnings Forecast

Key Atreca Financial Ratios

  • The Interest Expense is 0.00% of Operating Income.
  • Per Share Earnings over the last 6 years have been positive in 4 years.

Atreca Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Biotechnology
Sector: Healthcare
Current Symbol: BCEL
CUSIP: 04965G
Website: atreca.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

BCEL Technical Analysis vs Fundamental Analysis

Sell
18
Atreca (BCEL) is a Sell

Is Atreca a Buy or a Sell?

  • Atreca stock is rated a Sell
    The current Atreca [BCEL] share price is $0.08. The Score for BCEL is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.